Status:
COMPLETED
Major and Macular Branched Retinal Venous Occlusion
Lead Sponsor:
Hallym University Medical Center
Conditions:
Macular Edema
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Although it is important in the clinical management to classify BRVO into subtypes based on the location of the occlusion (major or macular), few studies have provided such information\[8,9\]. The aim...
Detailed Description
Branch retinal vein occlusion is the second most frequent major retinal vascular disease after diabetic retinopathy. One of the main reasons for visual loss in BRVO is the development of macular edema...
Eligibility Criteria
Inclusion
- macular edema involving the center of the fovea with a minimum central macular thickness at baseline of ≥250 μm
Exclusion
- previous vitreoretinal surgery, intravitreal injections or laser treatment
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01219205
Start Date
March 1 2008
End Date
August 1 2010
Last Update
October 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ji Won Lim
Chuncheon, Gangwon-do, South Korea, 200-704